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ABSTRACT
Introduction: Tuberculosis (TB) persists as a severe global public health issue. 
The aim of the present study was to evaluate the performance of an in-house TB 
PCR (polymerase chain reaction) in sputum.
Methods: DNA from sputum specimens were submitted to a nested-PCR protocol for 
the IS6110 region detection. PCR results were compared to those of the traditional 
methods for TB diagnosis, i.e., acid-fast bacilli (AFB) smear microscopy and culture. 
We analyzed sputum samples obtained from 133 patients.
Results: A total of 48 (36%) cultures yielded indeterminate results due to contamination. 
This high contamination rate may be explained by the fact that samples from fibrocystic 
patients were included in this study. Additionally, other five samples were positive for 
nontuberculous mycobacteria (NTM). Therefore, it was possible to compare 80 patients 
for M. tuberculosis detection. We found 14 positive samples: five presented positive 
results in the three methods (5/14; 35.7%), two were positive in culture and PCR (2/14; 
14.3%), one was positive in AFB and PCR (1/14; 7.1%), five were positive only in PCR 
(5/14; 35.7%) and 1 was positive only in culture (1/14; 7.1%). Thus, positivity rates 
for each technique were: 7.5% for AFB (6/80), 10% for culture (8/80) and 16.25% for 
PCR (13/80). Among the 48 patients who had indeterminate results in sputum culture, 
two samples were positive in PCR.
Conclusion: Considering the limitations of the traditional methods, the use of PCR 
as a molecular technique could be advantageous for TB diagnosis.
Keywords: Mycobacterium sp.; pulmonary tuberculosis; nucleic acid amplification 
tests; polymerase chain reaction
Tuberculosis (TB) persists as a severe global public health threat1-3 
with more than 9 million new cases worldwide every year4. Inadequate 
case detection and low cure rates have been identified as reasons for the 
mounting global TB burden5. Consequently, the development of methods that 
aid in prompt and correct identification of infected patients is very important. 
This will contribute to proper treatment adherence, which is the main strategy 
to reduce TB epidemics6.
Concerning diagnosis, acid-fast bacilli (AFB) smear microscopy and sputum 
culture have been advocated as two useful laboratory tools for diagnosis of 
pulmonary TB. However, these conventional tests may present limitations. 
AFB smear microscopy is a rapid and inexpensive test, although with limited 
accuracy due to its poor sensitivity (45%-80% in culture-confirmed pulmonary TB 
cases)7,8, whereas TB culture requires long periods of incubation (2-8 weeks).
In this scenario, nucleic acid amplification (NAA) tests have emerged as 
promising alternatives for TB diagnosis9. Polymerase chain reaction (PCR) is 
the best known and most widely used NAA test. NAA tests are categorized as 
commercial (kit-based) or in-house (“home-brew”). In-house tests are those 
assays where the investigators design their own protocols. In-house tests 
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are commonly used in developing countries where 
commercial kits are hardly affordable9. Guidelines 
recommend the use of NAA tests on at least one 
respiratory specimen from patients with negative 
AFB smear in whom a diagnosis of TB is being 
considered1,7,10,11. The aim of the present study was 
to evaluate the performance of an in-house TB PCR, 
in comparison to AFB smear microscopy and TB 
culture in sputum from patients with suspected TB.
METHODS
Patients’ Samples
Consecutive patients with suspected diagnosis of 
TB attending at Hospital de Clínicas de Porto Alegre 
(a tertiary care hospital in southern Brazil) from 
October 2007 to March 2008, for whom a sputum 
sample for TB culture was ordered, were considered 
for inclusion in the study. There was no exclusion 
criterion. Samples in this study were taken as part of 
standard care. Ethical approval was granted by the 
Ethical Committee of Hospital de Clínicas de Porto 
Alegre (no. 07-363).
Microbiological Methods
Microscopic examination of sputum smears for 
AFB using the Ziehl-Neelsen method was performed 
in all samples. For culture, the samples were 
digested and decontaminated using 2% NaOH with 
N-acetylcysteine. Afterwards, the samples were 
subcultured in Löwenstein-Jensen media. All cultures 
were incubated at 37 °C for 8 weeks and checked 
weekly. Any colony consistent with Mycobacterium 
sp. during this period was submitted to AFB staining 
to confirm the presence of bacterium12.
All positive cultures were subcultured in liquid 
broth BBL MGIT and incubated in the automated 
system Mycobacteria Growth Indicator Tube (MGIT) 
960 System (BBL, Becton Dickinson Microbiology 
Systems, Hunt Valley). The p-nitrobenzoic acid (PNB) 
test was performed to differentiate the Mycobacterium 
tuberculosis (MTB) complex from nontuberculous 
mycobacteria (NTM).
Polymerase Chain Reaction (PCR)
A volume of 1 mL from all decontaminated samples 
was stored at –20 °C to further perform the PCR 
technique. The samples were thawed and treated with 
proteinase K. The Qiagen kit was used, according 
to manufacturer’s instructions for DNA extraction. 
The PCR technique was performed in duplicate for 
each sample, using a nested protocol with primers 
for the IS6110 insertion sequence. The sequence of 
primers used was described by Sechi et al.13 for the 
MTB complex (table 1).
An aqueous mixture containing 1.25 U of Taq 
polymerase DNA enzyme (Super-Therm, JMR Holdings, 
London, UK), buffer, 1.5 mM of MgCl2, 250 µM of 
dNTP (Abgne, Epson, UK), and 500 nM of external 
primers was used in this reaction. The amplification 
was conducted in a Techne thermocycler (Techne, 
New Jersey, USA). The reaction consisted of initial 
denaturation at 94 °C for 1 minute and 40 seconds, 
followed by 33 cycles of denaturation at 94 °C for 
30 seconds, annealing at 55 °C for 30 seconds, and 
polymerization at 72 °C for 30 seconds. In the second 
amplification reaction, 2 µL of internal primers were 
added to the product of the first reaction in a mixture 
with the same proportion of the reagents above. The 
reaction consisted of initial denaturation at 94 °C for 
45 seconds followed by 33 cycles of denaturation 
at 94 °C for 20 seconds, annealing at 55 °C for 
20 seconds, and polymerization at 72 °C for 30 
seconds.
The final products from the second reaction of 
nested PCR were run on 2% agarose gel stained with 
ethidium bromide. All samples that showed a DNA 
band of 170 base pairs were considered positive.
For patients with more than one sputum sample 
collected for AFB or TB culture, only the first sample 
was processed for TB PCR and included in our 
analysis.
RESULTS
In the period described above, 201 consecutive 
samples were processed. These samples were obtained 
from 133 patients (77 males and 56 females) with a 
mean age of 44.9 years. A total of 30.8% (41/133) 
samples were obtained from cystic fibrosis (CF) 
patients and 14.3% (19/133) were from HIV positive 
patients. In addition, there were 21.8% (29/133) of 
patients with reported previously TB (table 2).
Culture for diagnosis of tuberculosis was positive in 
13 (9.8%) patients. Eight isolates from these patients 
were identified as MTB and five were identified as NTM 
in the PNB test. However, 48 (36%) cultures yielded 
indeterminate results due to contamination (growth 
Table 1: Sequence of primers used in polymerase chain reaction for tuberculosis.
External primers TB290TB856
5’GGC GGG ACA ACG CCG AAT TGC GAA
5’CGA GCG TAG GCG TCG GTG ACA AAG 600pb
Internal primers TB500TB607
5’TAC TAC GAC CAG ATC
5’TTG GTG ATC AGC CGT 170pb
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of yeasts or other bacteria). Among contaminated 
cultures, 23 (47.9%) were obtained from CF patients.
AFB was detected in only eight samples (6%); 
five were positive for MTB (culture and PCR results) 
but three presented either negative or indeterminate 
culture results. Among these latter three samples, 
two presented positive PCR for MTB.
According to the PCR assay, a total of 15 (11.3%) 
patients presented positive results for MTB complex. 
Seven were also positive for MTB in culture and eight 
presented either negative culture (six samples) or 
contaminated (two samples). Noteworthy, all five 
NTM identified by culture proved to be negative for 
MTB complex by PCR (table 3).
It was possible to compare the AFB and PCR 
techniques with culture assays with regard to MTB 
detection in 80 patients (excluding 48 cultures with 
indeterminate results and five cultures positive for 
NTM). The following positivity rates were observed for 
each technique: 7.5% for AFB smear (6/80), 10% for 
culture (8/80) and 16.25% for PCR (13/80). Among 
the 14 positive samples, five presented positive 
results in the three methods (5/14; 35.7%), two were 
positive in culture and PCR (2/14; 14.3%), one was 
positive in AFB smear and PCR (1/14; 7.1%), five 
were positive only in PCR (5/14; 35.7%), and one 
was positive only in culture (1/14; 7.1%) (table 3).
The sensitivity of PCR was 87.5%, specificity was 
91.7%, positive predictive value (PPV) was 53.8%, 
and negative predictive value (NPV) was 98.5%.
Additionally, we could observe that, in the 48 patients 
whose culture was lost due to contamination, one 
sample was positive in AFB smear and PCR, one 
sample was positive only in AFB smear, and 1 sample 
was positive only in PCR (table 3).
DISCUSSION
Conventional tests for laboratory confirmation 
of TB include AFB smear microscopy and culture14. 
In the present study, a NAA test (in-house nested-PCR 
protocol), was evaluated as an adjunct test in the 
diagnostic strategy for TB detection in sputum samples. 
With the PCR technique (considering MTB detection) 
the positivity rate obtained was 16.25% (13/80) and 
cultural method the positivity rate was 7.5% (6/80) 
and 10% (8/80), respectively. Other important finding 
was that among positive samples for PCR, 9 were 
positive for one of the traditional methodologies.
Only one sample positive for TB in the culture 
method had negative PCR. This fact can be associated 
Table 2: Characteristics of patients participating in this study.
HIV status Cystic fibrosis (CF) Previous diagnosis of 
Mycobacterium
Number of patients
- - - 56
- + - 34
- + + 7 (3 TB + 4 NTM)
+ - - 14
+ - + 5 (only TB)
- - + 17 (only TB)
Total = 133




AFB PCRM. tuberculosis NTM
66 - - - -
45 NR NR - -
5 - - - +
5 - + - -
5 + - + +
2 + - - +
1 + - - -
1 - - + +
1 NR NR - +
1 NR NR + +
1 NR NR + -
NR = no result due contamination; “-“ = negative; “+” = positive and NTM = nontuberculous mycobacteria.
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with the presence of inhibiting substances of DNA 
polymerase enzyme in the sputum11. In contrast, 
two samples were positive in AFB and PCR but 
negative or indeterminate in culture. Therefore, the 
culture method may produce false-negative results, 
although it is traditionally considered as gold standard. 
The culture technique may be influenced by a variety 
of conditions that do not influence the PCR assay, 
which may explain, at least partially, the finding of 
higher positivity rates in the PCR technique. In this 
study, among the six patients positive for MTB only in 
the PCR technique, there were two samples obtained 
from patients previously diagnosed with TB.
Considering the 80 patients tested by the three 
methods in our study, the sensitivity and specificity 
rates of PCR compared to culture was 87.5% and 
91.7%, respectively. A study conducted by Rozales et al. 
showed that real-time PCR (qPCR) and conventional 
in-house PCR (nPCR) also presented high sensitivity 
and specificity (qPCR 97.6% and 91.5%, nPCR 85.7% 
and 92.7%, respectively) compared to culture3. Another 
study in that UK that used commercial NAA tests, 
found a sensitivity rate of 87% and a specificity rate 
of 75%1. We believe that our nPCR technique has 
comparable performance to commercial tests that 
have their use recommended only in smear-positive 
samples.
In this study, we could observe an important 
limitation of the culture method: contamination. 
A considerable number of culture samples yielded 
indeterminate results (48/133, 36%). Among the 
48 patients whose samples were contaminated in 
the culture method, there were two positive samples 
were in PCR.
CONCLUSION
The current study presents some limitations, 
such as the lack of sequencing of PCR positive 
samples, in order to confirm the good performance 
of PCR and its positive results, as well as the use 
of internal control to validate negative samples. 
Respecting the limitations of this study, the results 
obtained are promising with regard to the use of 
PCR in TB diagnosis.
Furthermore, considering the limitations of the gold 
standard method discussed in this study (contaminated 
cultures, unviable growth due to the decontamination 
method, etc.) and the fact that culture is considered a 
cumbersome and time-consuming technique14,15, the 
use of PCR could be advantageous for TB diagnosis. 
PCR could reduce diagnosis time, which will impact 
directly on the reduction of the transmission chain 
of this important disease10.
In summary, the addition of PCR test can contribute 
greatly to TB diagnosis, especially in samples whose 
culture was lost due to contamination.
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